Qbic Fund logo

Qbic Fund

North America, Wisconsin, United States, Belgium

Description

Qbic Fund is a prominent inter-university venture capital fund based in Belgium, uniquely positioned to invest in high-tech spin-off companies originating from its partner universities and knowledge centers, including Ghent University, Vrije Universiteit Brussel (VUB), University of Antwerp, UZ Gent, and VIB. The fund operates with a multi-sector focus, primarily targeting innovations in Life Sciences, Information and Communication Technology (ICT), and Materials/Cleantech. Its strategic alignment with leading academic institutions provides a direct pipeline to groundbreaking research and entrepreneurial talent, fostering the commercialization of cutting-edge technologies.

The fund's investment strategy centers on early-stage opportunities, typically engaging with companies during their seed and Series A rounds. Qbic Fund plays a crucial role in bridging the gap between academic discovery and market viability, providing not only capital but also strategic guidance and access to a broad network. They seek to support ventures with strong intellectual property, significant market potential, and scalable business models, aiming to transform scientific breakthroughs into successful commercial enterprises.

Financially, Qbic Fund has demonstrated substantial capacity to support its portfolio companies. Their latest fund, Qbic Fund III, launched with an impressive €100 million (approximately $108 million USD) in committed capital, signifying a robust commitment to the Belgian innovation ecosystem. For initial investments, Qbic typically writes checks ranging from €500,000 to €3 million (approximately $540,000 to $3.24 million USD), demonstrating their commitment to providing meaningful early-stage capital. Furthermore, they have the capacity to provide significant follow-on funding, potentially investing up to €10 million over the lifecycle of a single company, enabling sustained growth and development. To date, Qbic Fund has supported over 40 spin-off companies, contributing significantly to job creation and economic development within Belgium.

Investor Profile

Qbic Fund has backed more than 47 startups, with 7 new investments in the last 12 months alone. The firm has led 12 rounds, about 26% of its total and boasts 8 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series Unknown, Series A rounds (top funding stages).
  • Majority of deals are located in Belgium, The Netherlands.
  • Strong thematic focus on Biotechnology, Software, Health Care.
  • Typical check size: $540K – $3.2M.

Stage Focus

  • Seed (38%)
  • Series Unknown (26%)
  • Series A (17%)
  • Series B (13%)
  • Series C (2%)
  • Angel (2%)
  • Pre Seed (2%)

Country Focus

  • Belgium (96%)
  • The Netherlands (2%)

Industry Focus

  • Biotechnology
  • Software
  • Health Care
  • Medical
  • Information Technology
  • Therapeutics
  • Semiconductor
  • Life Science
  • Chemical
  • Service Industry
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Qbic Fund frequently co-invest with?

imec.xpand
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 5
AI
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 3
VIB
Europe, Oost-Vlaanderen, Belgium, Gent
Co-Investments: 7
Co-Investments: 4
Innovation Fund
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 4
imec.istart
Europe, Oost-Vlaanderen, Belgium, Gent
Co-Investments: 4
V-Bio Ventures
Europe, Oost-Vlaanderen, Belgium, Gent
Co-Investments: 4
Capricorn Partners
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 4
PMV
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 14
Ackermans & van Haaren
Europe, Antwerpen, Belgium, Antwerpen
Co-Investments: 4

Which angels does Qbic Fund often collaborate with?

MA
Europe, Antwerpen, Belgium
Shared Deals: 1
LK
Europe, Belgium
Shared Deals: 1
PK
Europe, Belgium
Shared Deals: 1
WM
North America, New York, United States, New York
Shared Deals: 1
PD
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Shared Deals: 1

What are some of recent deals done by Qbic Fund?

Animab

Gent, Oost-Vlaanderen, Belgium

Animab is a biotechnology company specializing in proprietary technology that supports livestock health.

Biotechnology
Series BJul 1, 2025
Amount Raised: $11,805,400
Spica Therapeutics

Antwerp, Antwerpen, Belgium

Spica Therapeutics is a biotech company to transform macrophage biology into breakthrough therapies for patients.

BiotechnologyTherapeutics
SeedJun 4, 2025
Amount Raised: $11,421,105

Eyeo is fundamentally redefining image sensing by eliminating decades-old limitations.

SeedMay 7, 2025
Amount Raised: $17,043,498
Aloxy

Antwerpen, Antwerpen, Belgium

Aloxy offers an industrial internet of things solution for the industry to monitor manual valve position.

IndustrialInternet of ThingsService Industry
Series UnknownMar 11, 2025
Amount Raised: $8,076,777
Pleevi

Brussel, Brussels Hoofdstedelijk Gewest, Belgium

Pleevi is revolutionizing workplace EV charging with AI-driven software that enables greener and more cost-effective charging sessions.

BatteryCharging InfrastructureElectric Vehicle
Pre SeedJan 30, 2025
Amount Raised: $1,042,605
Swave Photonics

Leuven, Vlaams-Brabant, Belgium

Swave Photonics is a fabless semiconductor firm that designs and manufactures holographic chips based on diffractive photonics technology.

Augmented RealityManufacturingMetaverseSemiconductor
Series AJan 3, 2025
Amount Raised: $27,733,581
Weavely

Brussel, Brussels Hoofdstedelijk Gewest, Belgium

Weavely is a Figma plugin that creates, customizes, and publishes AI-generated forms and surveys, after which replies are collected.

MarketingSoftwareWeb Development
SeedAug 21, 2024
Amount Raised: $1,000,794
Confo Therapeutics

Brussels, Brussels Hoofdstedelijk Gewest, Belgium

Confo Therapeutics is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need.

BiotechnologyHealth CareMedicalTherapeutics
Series BJul 26, 2024
Amount Raised: $65,148,419
Flindr Therapeutics

Amsterdam, Noord-Holland, The Netherlands

Flindr Therapeutics, a private biotech company develops next-generation precision oncology treatments.

BiotechnologyHealth CareTherapeutics
Series AApr 24, 2024
Amount Raised: $21,400,056
AmphiStar

Ghent, Oost-Vlaanderen, Belgium

AmphiStar is a biotechnology firm that makes sophorolipid products from biobased waste- and side streams.

BiotechnologyLife ScienceTechnical Support
SeedApr 18, 2024
Amount Raised: $6,385,533